Wanbury has completed the United States Food and Drug Administration (USFDA) inspection at its major API facility in Tanuku Plant, Andhra Pradesh with five observations. The same is being addressed and will be resolved by the Regulatory Team. The audit was carried out for a period of 5 days and concluded on March 2, 2018.
Wanbury is a pharmaceutical company and offers active pharmaceutical ingredient (API) in over 70 countries.